The Union Health Ministry is prioritising 219 districts for HIV/AIDS interventions. Haryana and Delhi are key focus areas. The National AID...

The act seeks to prevent and control the spread of HIV and AIDS and and creates mechanisms for redressing the complaints of persons infecte...

The panel has also asked the ministry to devise a mechanism for providing an expanded access to subsidised anti-retroviral therapy for poor...

The FDC drug ‘Darunavir+Ritonavir’ is an anti-retroviral medication indicated for the treatment of human immunodeficiency virus (HIV-1) in ...

New York, Sep 25 (IANS) Using reliable biomarkers, researchers have found a unique epigenetic footprint which offers them insight into how ...

AIDS-related deaths have fallen by 42 per cent since 2004 -- the year that saw the largest number of deaths in the history of the epidemic.

Starting anti-HIV treatment within two weeks of the diagnosis of tuberculosis improved survival among patients with both infections, a new ...

Cipla has been awarded $188.95 million tender for anti-retrovirals drugs by Global Fund which would enable it to supply the medicines to ov...

The centre, owned by the Municipal Corporation of Greater Mumbai (MCGM), has been built by L&T, which will also operate it.

The operating profit dropped 4% and operating margin contracted 530 bps to 16.8%. Net profit also declined by 6% over the year ago level.

US Food and Drug Administration provided marketing approval to its partner in US, Salix Pharmaceuticals, for Crofelemer 125 mg delayed-rele...

Cipla will work to produce an appropriate 4-in-1 combination sachet product for easy mixing into food or liquids such as water, juice, or b...

US-based bio-pharmaceutical company Gilead Sciences on Tuesday entered into new licensing pacts with four Indian firms.

Ranbaxy has entered into an agreement with US-headquartered Gilead Sciences to manufacture and market three new generic HIV/AIDS drugs.

Generic anti-retroviral drugs manufactured by Indian cos have brought down the cost of first line treatment for HIV patients from $800 to $...

Two new drugs against tuberculosis have reached the advanced stages of clinical trial and could be made available for use by 2012-2014.

Pharmacuetical company, Matrix Laboratories Ltd on Friday said it signed a licensing agreement with Gilead for manufacture and sale of a ge...